Skip to main content

Protalix BioTherapeutics, Inc. (DE) Common Stock (NY: PLX )

1.780 UNCHANGED
Official Closing Price Updated: 4:10 PM EST, Dec 26, 2024 Add to My Watchlist

Other Filings

Form 8-K
Source: SEC/Edgar
September 26, 2012
Form 8-K
Source: SEC/Edgar
August 12, 2012
Form 8-K
Source: SEC/Edgar
August 08, 2012
Form 8-K
Source: SEC/Edgar
July 17, 2012
Form S-8
Source: SEC/Edgar
July 15, 2012
Form 8-K
Source: SEC/Edgar
July 01, 2012
Form 8-K
Source: SEC/Edgar
June 24, 2012
Form 8-K
Source: SEC/Edgar
June 21, 2012
Form 8-K
Source: SEC/Edgar
June 17, 2012
Form 8-K
Source: SEC/Edgar
June 10, 2012
Form ARS
Source: SEC/Edgar
May 29, 2012
Form 8-K
Source: SEC/Edgar
May 28, 2012
Form DEF 14A
Source: SEC/Edgar
May 20, 2012
Form 8-K
Source: SEC/Edgar
May 09, 2012
Form PRE 14A
Source: SEC/Edgar
May 08, 2012
Form 8-K
Source: SEC/Edgar
May 01, 2012
Form 8-K
Source: SEC/Edgar
March 18, 2012
Form 8-K
Source: SEC/Edgar
February 22, 2012
Form 8-K
Source: SEC/Edgar
February 15, 2012
Form 424B5
Source: SEC/Edgar
February 15, 2012
Form 8-K
Source: SEC/Edgar
February 14, 2012
Form 424B5
Source: SEC/Edgar
February 14, 2012
Form SC 13G/A
Source: SEC/Edgar
February 09, 2012
Form 8-K
Source: SEC/Edgar
February 08, 2012
Form SC 13G
Source: SEC/Edgar
February 08, 2012
Form CT ORDER
Source: SEC/Edgar
January 31, 2012
Form 8-K
Source: SEC/Edgar
January 25, 2012
Form SC 13G/A
Source: SEC/Edgar
January 16, 2012
Form 8-K
Source: SEC/Edgar
December 12, 2011
Form 8-K
Source: SEC/Edgar
December 05, 2011
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.